Hansbiomed (Thailand) is one of the 7 branches under Hansbiomed Corp. South Korea, USA, China, UK, Thailand, Mexico, and Colombia
Hansbiomed Co., Ltd. received approval from the KFDA in 2005 to establish the first tissue bank in Korea. There were various companies, research centers, and universities that were researching artificial organs and tissue technology in Korea. However, Hansbiomed Co., Ltd. was the only one to receive an approval to establish the tissue bank.
Human tissue transplant materials were being used in medical centers, but there were no set laws regarding the items of use, which led to black trade and other various problems when we obtained the approval to establish the first tissue bank of Korea. In 2017-2018, a cell therapy product research center was established in Seoul, Korea, to transfer knowledge of neural stem cell technology. Hansbiomed (Thailand) Co., Ltd. was established in Thailand in 2018. As a global leading bio-company, Hansbiomed specializes in biologics, medical devices, and professional cosmeceutical products. With a dedicated R&D team focused on innovation and quality, we provide a broad range of products to specifically meet our providers’ needs, such as aesthetic medical devices, bone graft material, acellular dermal matrix, hair implants, and PDO lifting. Selected as “World Top-Class Product Company” sponsored by the Ministry of Commerce, Industry and Energy in 2002 and 2010.Hans Biomed Co.’s receiving the award (World Top-Class Product Company) implies that it was acknowledged as an excellent export-driven company.
OUR HISTORY
About us
Hansbiomed (Thailand) is one of the 7 branches under Hansbiomed Corp. South Korea, USA, China, UK, Thailand, Mexico, and Colombia
Hansbiomed Co., Ltd.
received approval from the KFDA in 2005 to establish the first tissue bank in Korea. There were various companies, research centers, and universities that were researching artificial organs and tissue technology in Korea. However, Hansbiomed Co., Ltd. was the only one to receive an approval to establish the tissue bank.
Human tissue transplant materials were being used in medical centers, but there were no set laws regarding the items of use, which led to black trade and other various problems when we obtained the approval to establish the first tissue bank of Korea. In 2017-2018, a cell therapy product research center was established in Seoul, Korea, to transfer knowledge of neural stem cell technology. Hansbiomed (Thailand) Co., Ltd. was established in Thailand in 2018. As a global leading bio-company, Hansbiomed specializes in biologics, medical devices, and professional cosmeceutical products. With a dedicated R&D team focused on innovation and quality, we provide a broad range of products to specifically meet our providers’ needs, such as aesthetic medical devices, bone graft material, acellular dermal matrix, hair implants, and PDO lifting. Selected as “World Top-Class Product Company” sponsored by the Ministry of Commerce, Industry and Energy in 2002 and 2010.Hans Biomed Co.’s receiving the award (World Top-Class Product Company) implies that it was acknowledged as an excellent export-driven company.
Our history
Established Hansbiomed Corp. in South Korea
Registered US FDA
Approval Korean FDA
Certified by European CE
Established Hansbiomed (Thailand)
Registered China CFDA
Registered Thailand FDA